News|Poll|February 25, 2016

Head-to-Toe Rash on a 17-year-old Boy

Author(s)ReelDx

VIDEO: The non-pruritic rash began on his chest and spread rapidly over 3 days. Get a closer look; what's your diagnosis?

A 17-year-old boy presents with a head-to-toe non-blanching rash that began on his chest and spread rapidly over 3 days. Non-pruritic; mild discomfort. Low fever; recent URI. No allergies; other PMH, noncontributory. Vitals, WNL.

What's your diagnosis?

Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.

Related to this article

September 30th, 2026

Lebrikizumab Improves Hand and Foot Atopic Dermatitis in Phase 3b Trial

EADV 2026: Lebrikizumab improved hand and foot clearance, itch, and pain at 16 weeks versus placebo in a phase 3b atopic dermatitis trial.

September 28th, 2026

FDA Expands Baricitinib Approval to Adolescents With Severe Alopecia Areata

The FDA has approved baricitinib for adolescents aged 12 and older with severe alopecia areata, marking the first systemic oral therapy cleared for this population.

September 14th, 2026

FDA Grants Priority Review to Zasocitinib for Plaque Psoriasis

Takeda’s oral TYK2 inhibitor showed rapid skin clearance in phase 3 psoriasis trials as FDA fast-tracks review; decision expected early 2027.

Head-to-Toe Rash on a 17-year-old Boy

Related to this article

Trending on Patient Care Online

Atrial Fibrillation Stroke Prevention: Expert Guidance for Primary Care Physicians

Lebrikizumab Improves Hand and Foot Atopic Dermatitis in Phase 3b Trial

Detecting Atrial Fibrillation in Primary Care: Warning Signs and Modifiable Risk Factors

CagriSema Alters Food-Cue Responses, Reduces Organ Fat in New Analyses

5 FDA Decisions for Primary Care to Know from September 2026